Login / Signup
Cooper Beaman
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 2
Top Topics
Patient Reported
Free Survival
Cell Cycle
Tyrosine Kinase
Top Venues
Cancer research
Cancers
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Deepak Rohila
,
In Hwan Park
,
Timothy V Pham
,
Jonathan R Weitz
,
Tatiana Hurtado de Mendoza
,
Suresh Madheswaran
,
Mehreen Ishfaq
,
Cooper Beaman
,
Elisabette Tapia
,
Siming Sun
,
Jay Patel
,
Pablo Tamayo
,
Andrew M Lowy
,
Shweta Joshi
Syk inhibition reprograms tumor-associated macrophages and overcomes gemcitabine-induced immunosuppression in pancreatic ductal adenocarcinoma.
Cancer research
(2023)
Mehreen Ishfaq
,
Timothy Pham
,
Cooper Beaman
,
Pablo Tamayo
,
Alice L Yu
,
Shweta Joshi
BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma.
Cancers
13 (4) (2021)